Sarcoma classification by DNA methylation profiling C Koelsche, D Schrimpf, D Stichel, M Sill, F Sahm, DE Reuss, M Blattner, ... Nature communications 12 (1), 498, 2021 | 296 | 2021 |
MALDI TOF imaging mass spectrometry in clinical pathology: a valuable tool for cancer diagnostics J Kriegsmann, M Kriegsmann, R Casadonte International journal of oncology 46 (3), 893-906, 2015 | 180 | 2015 |
Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation A Gewies, O Gorka, H Bergmann, K Pechloff, F Petermann, KM Jeltsch, ... Cell reports 9 (4), 1292-1305, 2014 | 157 | 2014 |
Regulation of epithelial plasticity determines metastatic organotropism in pancreatic cancer M Reichert, B Bakir, L Moreira, JR Pitarresi, K Feldmann, L Simon, ... Developmental cell 45 (6), 696-711. e8, 2018 | 125 | 2018 |
Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion Y Lan, M Moustafa, M Knoll, C Xu, J Furkel, A Lazorchak, TL Yeung, ... Cancer cell 39 (10), 1388-1403. e10, 2021 | 110 | 2021 |
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix H Jiang, RJ Torphy, K Steiger, H Hongo, AJ Ritchie, M Kriegsmann, ... The Journal of clinical investigation 130 (9), 4704-4709, 2020 | 93 | 2020 |
Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin‐fixed paraffin‐embedded tissues R Casadonte, M Kriegsmann, F Zweynert, K Friedrich, G Bretton, M Otto, ... Proteomics 14 (7-8), 956-964, 2014 | 90 | 2014 |
Spatial and temporal heterogeneity of panel-based tumor mutational burden in pulmonary adenocarcinoma: separating biology from technical artifacts D Kazdal, V Endris, M Allgäuer, M Kriegsmann, J Leichsenring, ... Journal of Thoracic Oncology 14 (11), 1935-1947, 2019 | 88 | 2019 |
MALDI mass spectrometry imaging: A cutting‐edge tool for fundamental and clinical histopathology R Longuespée, R Casadonte, M Kriegsmann, C Pottier, ... PROTEOMICS–Clinical Applications 10 (7), 701-719, 2016 | 88 | 2016 |
Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity … M Kriegsmann, V Endris, T Wolf, N Pfarr, A Stenzinger, S Loibl, C Denkert, ... Oncotarget 5 (20), 9952, 2014 | 87 | 2014 |
Deep learning for the classification of small-cell and non-small-cell lung cancer M Kriegsmann, C Haag, CA Weis, G Steinbuss, A Warth, C Zgorzelski, ... Cancers 12 (6), 1604, 2020 | 85 | 2020 |
Site‐to‐site reproducibility and spatial resolution in MALDI–MSI of peptides from formalin‐fixed paraffin‐embedded samples A Ly, R Longuespée, R Casadonte, P Wandernoth, K Schwamborn, ... PROTEOMICS–Clinical Applications 13 (1), 1800029, 2019 | 85 | 2019 |
Reliable entity subtyping in non-small cell lung cancer by matrix-assisted laser desorption/ionization imaging mass spectrometry on formalin-fixed paraffin-embedded tissue … M Kriegsmann, R Casadonte, J Kriegsmann, H Dienemann, ... Molecular & Cellular Proteomics 15 (10), 3081-3089, 2016 | 83 | 2016 |
A laser microdissection-based workflow for FFPE tissue microproteomics: Important considerations for small sample processing R Longuespée, D Alberts, C Pottier, N Smargiasso, G Mazzucchelli, ... Methods 104, 154-162, 2016 | 80 | 2016 |
Increases in tumor N‐glycan polylactosamines associated with advanced HER2‐positive and triple‐negative breast cancer tissues DA Scott, R Casadonte, B Cardinali, L Spruill, AS Mehta, F Carli, ... PROTEOMICS–Clinical Applications 13 (1), 1800014, 2019 | 71 | 2019 |
Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast—implications for tumor biology and pathological diagnosis N Pfarr, M Kriegsmann, P Sinn, F Klauschen, V Endris, E Herpel, ... Genes, Chromosomes and Cancer 54 (7), 444-452, 2015 | 71 | 2015 |
MALDI imaging mass spectrometry—from bench to bedside K Schwamborn, M Kriegsmann, W Weichert Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1865 (7), 776-783, 2017 | 70 | 2017 |
Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells M Rosenbaum, A Gewies, K Pechloff, C Heuser, T Engleitner, T Gehring, ... Nature communications 10 (1), 2352, 2019 | 69 | 2019 |
Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study CJ Nattenmüller, M Kriegsmann, D Sookthai, RT Fortner, A Steffen, ... BMC cancer 18, 1-8, 2018 | 69 | 2018 |
Molecular driver alterations and their clinical relevance in cancer of unknown primary site H Löffler, N Pfarr, M Kriegsmann, V Endris, T Hielscher, P Lohneis, ... Oncotarget 7 (28), 44322, 2016 | 66 | 2016 |